Home › Astrocytoma › Minnesota › Rochester
Astrocytoma clinical trials in Rochester, MN
3 studies for Astrocytoma are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- Mayo Clinic - Rochester, Rochester
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
RecruitingPhase 1/2
- Mayo Clinic in Rochester, Rochester
GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
RecruitingPhase 2
- Mayo Clinic in Rochester, Rochester
Astrocytoma trials in other cities
- Houston, TX14 studies
- Boston, MA13 studies
- New York City, NY9 studies
- Chicago, IL9 studies
- Miami, FL7 studies
- Seattle, WA7 studies
- Philadelphia, PA7 studies
- Washington, DC6 studies
- Columbus, OH6 studies
- Durham, NC6 studies
- San Francisco, CA5 studies
- Aurora, CO5 studies
Other studies in Rochester
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer37 studies
- Cancer (all types)30 studies
- Metastatic Cancer30 studies
- Ovarian Cancer29 studies
- Colorectal Cancer29 studies
- Multiple Myeloma24 studies
- Pancreatic Cancer23 studies
- Heart Failure22 studies
- Prostate Cancer22 studies
- Lung Cancer20 studies
- Endometrial Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.